Gerald M McGeehan

Title: Innovations of Gerald M McGeehan

Introduction

Gerald M McGeehan is a notable inventor based in Chester Springs, PA (US). He has made significant contributions to the field of pharmaceuticals through his innovative work. His research focuses on compounds that possess useful properties, particularly in the treatment of diseases associated with tumor necrosis factor (TNF).

Latest Patents

Gerald M McGeehan holds 1 patent for his invention related to substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) compounds. This invention is directed to compounds of a specific formula that exhibit pharmaceutical properties. These compounds are particularly useful for inhibiting the production or physiological effects of TNF, which is crucial in treating diseases associated with an excess of this factor. Additionally, the compounds can inhibit cyclic AMP phosphodiesterase, making them valuable in treating inflammatory and autoimmune diseases.

Career Highlights

Gerald M McGeehan has worked with Rhone-Poulenc Rorer Pharmaceuticals Inc., where he has contributed to the development of pharmaceutical compositions and methods for preparing these innovative compounds. His work has implications for treating various pathological conditions, including those involving tissue breakdown.

Collaborations

Throughout his career, Gerald has collaborated with notable colleagues such as Robert D Groneberg and Kent W Neuenschwander. These collaborations have likely enhanced the scope and impact of his research.

Conclusion

Gerald M McGeehan's contributions to pharmaceutical innovations demonstrate the importance of research in developing treatments for complex diseases. His work continues to influence the field and offers hope for patients suffering from conditions related to TNF.